Delivery systems / formulations for drugs with low water solubility

Delivery systems / formulations for drugs with low water solubility
Product Description

Develop delivery systems for drugs with low water solubility

Acon Pharmaceuticals

  • US
  • 2022
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Consultancy
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Finished Formulation products Distributor/Buyer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
Specifications
  • Selling Points
    Product Performance

Acon Pharmaceuticals

  • US
  • 2022
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Consultancy
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Finished Formulation products Distributor/Buyer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology

More Products from Acon Pharmaceuticals (2)

  • Liposome

    Product Liposome

    Development of liposome delivery systems for both small molecule drugs and biologics
  • Nanocrystals

    Product Nanocrystals

    Development of drug to nanocrystals for higher bioavailability or long acting

Acon Pharmaceuticals resources (1)

  • News siRNA and mRNA LNP

    ACON Pharma provides development of mRNA, siRNA lipid nanoparticle (LNP) products as therapeutics or vaccine.